Clinical Trial » Intervention Name » pramipexole

pramipexole

Study of (Mirapex) Pramipexole for the Early Treatment of Parkinsons Disease
31 May 2009
This is a double blind, placebo-controlled clinical trial of 15 months duration designed to examine early Mirapex (pramipexole) treatment vs. delayed Mirapex (pramipexole) treatment in ... 
Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease
22 Apr 2008
The purpose of this study is to determine whether there is a benefit to giving a dopamine agonist to a patient with Parkinson's disease who is already being treated with levodopa. ... 
Long-Term Safety Study of Open-Label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).
14 Jan 2008
The general aim of this study is to obtain long-term safety and tolerability data on pramipexole ER, in daily doses from 0.375mg to 4.5mg q.d, in patients who have previously completed a pramipexole ... 
Pivotal Study in Advanced Parkinsons Disease Patients
24 Apr 2007
The general aim of this trial is to determine the efficacy (as measured by the change from baseline to the end of the maintenance phase in the total score for UPDRS Parts II and III combined), ... 
Syndicate content